Literature DB >> 21119225

On epicardial potential reconstruction using regularization schemes with the L1-norm data term.

Guofa Shou1, Ling Xia, Feng Liu, Mingfeng Jiang, Stuart Crozier.   

Abstract

The electrocardiographic (ECG) inverse problem is ill-posed and usually solved by regularization schemes. These regularization methods, such as the Tikhonov method, are often based on the L2-norm data and constraint terms. However, L2-norm-based methods inherently provide smoothed inverse solutions that are sensitive to measurement errors, and also lack the capability of localizing and distinguishing multiple proximal cardiac electrical sources. This paper presents alternative regularization schemes employing the L1-norm data term for the reconstruction of epicardial potentials (EPs) from measured body surface potentials (BSPs). During numerical implementation, the iteratively reweighted norm algorithm was applied to solve the L1-norm-related schemes, and measurement noises were considered in the BSP data. The proposed L1-norm data term-based regularization schemes (with L1 and L2 penalty terms of the normal derivative constraint (labelled as L1TV and L1L2)) were compared with the L2-norm data terms (Tikhonov with zero-order and normal derivative constraints, labelled as ZOT and FOT, and the total variation method labelled as L2TV). The studies demonstrated that, with averaged measurement noise, the inverse solutions provided by the L1L2 and FOT algorithms have less relative error values. However, when larger noise occurred in some electrodes (for example, signal lost during measurement), the L1TV and L1L2 methods can obtain more accurate EPs in a robust manner. Therefore the L1-norm data term-based solutions are generally less perturbed by measurement noises, suggesting that the new regularization scheme is promising for providing practical ECG inverse solutions.

Mesh:

Year:  2010        PMID: 21119225     DOI: 10.1088/0031-9155/56/1/004

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  8 in total

1.  Inverse Electrocardiographic Source Localization of Ischemia: An Optimization Framework and Finite Element Solution.

Authors:  Dafang Wang; Robert M Kirby; Rob S Macleod; Chris R Johnson
Journal:  J Comput Phys       Date:  2013-10-01       Impact factor: 3.553

2.  Sensitivity of Noninvasive Cardiac Electrophysiological Imaging to Variations in Personalized Anatomical Modeling.

Authors:  Azar Rahimi
Journal:  IEEE Trans Biomed Eng       Date:  2015-01-21       Impact factor: 4.538

3.  Examining the Impact of Prior Models in Transmural Electrophysiological Imaging: A Hierarchical Multiple-Model Bayesian Approach.

Authors:  Azar Rahimi; John Sapp; Jingjia Xu; Peter Bajorski; Milan Horacek; Linwei Wang
Journal:  IEEE Trans Med Imaging       Date:  2015-08-04       Impact factor: 10.048

4.  Assessment of regularization techniques for electrocardiographic imaging.

Authors:  Matija Milanič; Vojko Jazbinšek; Robert S Macleod; Dana H Brooks; Rok Hren
Journal:  J Electrocardiol       Date:  2013-10-17       Impact factor: 1.438

5.  Binary optimization for source localization in the inverse problem of ECG.

Authors:  Danila Potyagaylo; Elisenda Gil Cortés; Walther H W Schulze; Olaf Dössel
Journal:  Med Biol Eng Comput       Date:  2014-07-10       Impact factor: 2.602

6.  A hybrid model of maximum margin clustering method and support vector regression for noninvasive electrocardiographic imaging.

Authors:  Mingfeng Jiang; Feng Liu; Yaming Wang; Guofa Shou; Wenqing Huang; Huaxiong Zhang
Journal:  Comput Math Methods Med       Date:  2012-11-01       Impact factor: 2.238

7.  Lp-norm regularization in volumetric imaging of cardiac current sources.

Authors:  Azar Rahimi; Jingjia Xu; Linwei Wang
Journal:  Comput Math Methods Med       Date:  2013-11-20       Impact factor: 2.238

8.  Physics-driven Spatiotemporal Regularization for High-dimensional Predictive Modeling: A Novel Approach to Solve the Inverse ECG Problem.

Authors:  Bing Yao; Hui Yang
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.